Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Instrumentation
Agilent to acquire cell analysis expert ACEA Biosciences
by Marc Reisch
October 7, 2018
| A version of this story appeared in
Volume 96, Issue 40
Agilent Technologies has signed a deal to buy ACEA Biosciences for $250 million. The privately held cell analysis instrument maker, founded in 2002, will expand Agilent’s portfolio of tools for life sciences research and clinical diagnostics. Agilent calls cell analysis a strategic growth area that it entered in 2015 with the $235 million acquisition of Seahorse Bioscience. Earlier this year, the firm bought Ireland-based Luxcel Biosciences, a maker of biosensors and assays for analyzing cell metabolism.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X